Jacques Galipeau

USPTO Granted Patents = 11 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 25(Granted Patents)

Location History:

Atlanta, GA (US) (2012 - 2021)
Madison, WI (US) (2023)

Company Filing History:

Children's Healthcare of Atlanta, Inc.

patents

2 out of 832,912

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11701389 - Methods of preserving mesenchymal stem cells (2023-07-18),

2. 11053292 - GM-CSF and IL-4 conjugates, compositions, and methods related thereto (2021-07-06),

3. 10464982 - Compositions of GM-CSF and interleukin fusions for immune modulation and uses related thereto (2019-11-05),

4. 10093709 - GM-CSF and IL-4 conjugates, compositions, and methods related thereto (2018-10-09),

5. 10072058 - Chimeric virus-like particles incorporating fusion GPI anchored GM-CSF and IL-4 conjugates (2018-09-11),

6. 9999666 - Uses of conjugates of GM-CSF and IL-7 to treat viral infections (2018-06-19),

7. 9688959 - Compositions, uses, and preparation of platelet lysates (2017-06-27),

8. 9657076 - GM-CSF and IL-4 conjugates, compositions, and methods related thereto (2017-05-23),

9. 9375465 - Conjugates of GM-CSF and IL-7, compositions and methods related thereto (2016-06-28),

10. 8524656 - GM-CSF and truncated CCL2 conjugates and methods and uses thereof (2013-09-03),

11. 8283449 - Interleukin-2/soluble TGA-beta type II receptor B conjugates and methods and uses thereof (2012-10-09),

Title: The Innovative Contributions of Jacques Galipeau in Stem Cell Research

Introduction

Jacques Galipeau is a prominent inventor located in Atlanta, GA, known for his groundbreaking work in the field of stem cell research. With a total of 11 patents to his name, he has made significant contributions that enhance the preservation and application of mesenchymal stem cells (MSCs) for clinical purposes. His inventive methodologies are shaping the future of regenerative medicine.

Latest Patents

Galipeau's latest patents include innovative methods for preserving mesenchymal stem cells, where he introduces a novel technique of mixing MSCs with interferon-gamma before cryopreservation. This technique aims to maintain the viability and functionality of MSCs, crucial for their application in clinical settings. Another significant patent focuses on GM-CSF and IL-4 conjugates, which involves creating polypeptide conjugates connected by a linker. This disclosure encompasses isolated nucleic acids encoding these polypeptide conjugates, along with vectors and protein expression systems that could potentially lead to enhanced therapeutic applications.

Career Highlights

Throughout his career, Jacques Galipeau has worked with prestigious institutions, notably Emory University and Children's Healthcare of Atlanta, Inc. His experience in these renowned organizations has allowed him to push the boundaries of research and innovation, particularly in the realm of cellular therapies and their applications in medicine.

Collaborations

Collaboration has been a key element in Galipeau's research endeavors. He has worked alongside esteemed colleagues such as Jiusheng Deng and Hsiang-Chuan Hsieh, contributing to a network of expertise that strengthens the research outcomes in stem cell technology. These partnerships exemplify the collaborative spirit that fuels advancements in medical science.

Conclusion

Jacques Galipeau's contributions to stem cell preservation and therapeutic techniques signify a remarkable progression in biomedical research. With a strong patent portfolio and valuable collaborations, he continues to influence the future of regenerative medicine and offers innovative solutions that promise to enhance clinical outcomes.

This text is generated by artificial intelligence and may not be accurate.